-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 JsMSut1MbHEi6KFwj9472xv6arb4FdN4zL7StMcQhLeGIF6T6UTu8BPT3t4mY0sH
 oWkjyOsZXkeV+xEMXHlbDg==

<SEC-DOCUMENT>0001209191-09-041620.txt : 20090821
<SEC-HEADER>0001209191-09-041620.hdr.sgml : 20090821
<ACCEPTANCE-DATETIME>20090821171527
ACCESSION NUMBER:		0001209191-09-041620
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20090820
FILED AS OF DATE:		20090821
DATE AS OF CHANGE:		20090821

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			EISENBERG JEFFREY F
		CENTRAL INDEX KEY:			0001224096

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-17254
		FILM NUMBER:		091029232

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVEN PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000815838
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				592767632
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		11960 SW 144TH ST
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33186
		BUSINESS PHONE:		3052535099

	MAIL ADDRESS:	
		STREET 1:		11960 SW 144TH STREET
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33185
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2009-08-20</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000815838</issuerCik>
        <issuerName>NOVEN PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>NOVN</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001224096</rptOwnerCik>
            <rptOwnerName>EISENBERG JEFFREY F</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O NOVEN PHARMACEUTICALS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>11960 S.W. 144TH STREET</rptOwnerStreet2>
            <rptOwnerCity>MIAMI</rptOwnerCity>
            <rptOwnerState>FL</rptOwnerState>
            <rptOwnerZipCode>33186</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Executive Vice President</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock ($.0001 par value)</value>
            </securityTitle>
            <transactionDate>
                <value>2009-08-20</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>U</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>11846</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>16.50</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1835</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Represents shares of restricted stock which became fully vested upon the change of control of Noven Pharmaceuticals, Inc. (&quot;Noven&quot;) at the time a subsidiary of Hisamitsu Pharmaceutical Co., Inc. (&quot;Hisamitsu&quot;) commenced payment for shares of Noven common stock pursuant to an Agreement and Plan of Merger among Noven, Hisamitsu and certain wholly-owned subsidiaries of Hisamitsu, dated as of July 14, 2009.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Jeffrey F. Eisenberg</signatureName>
        <signatureDate>2009-08-21</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----